Literature DB >> 10571165

Nonpeptidic SH2 inhibitors of the tyrosine kinase ZAP-70.

C B Vu1, E G Corpuz, S G Pradeepan, S Violette, C Bartlett, T K Sawyer.   

Abstract

The synthesis of a series of 1,2,4-oxadiazole analogs is discussed along with their ZAP-70 SH2 inhibitory activity. The tyrosine moiety in the original series has been replaced with nonpeptidic functional groups without a substantial loss of binding affinity.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10571165     DOI: 10.1016/s0960-894x(99)00524-7

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.

Authors:  Pijus K Mandal; Donald Limbrick; David R Coleman; Garrett A Dyer; Zhiyong Ren; J Sanderson Birtwistle; Chiyi Xiong; Xiaomin Chen; James M Briggs; John S McMurray
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

2.  Efficient delivery of cell impermeable phosphopeptides by a cyclic peptide amphiphile containing tryptophan and arginine.

Authors:  Amir Nasrolahi Shirazi; Rakesh Kumar Tiwari; Donghoon Oh; Antara Banerjee; Arpita Yadav; Keykavous Parang
Journal:  Mol Pharm       Date:  2013-04-15       Impact factor: 4.939

3.  Modification by covalent reaction or oxidation of cysteine residues in the tandem-SH2 domains of ZAP-70 and Syk can block phosphopeptide binding.

Authors:  Patrick R Visperas; Jonathan A Winger; Timothy M Horton; Neel H Shah; Diane J Aum; Alyssa Tao; Tiago Barros; Qingrong Yan; Christopher G Wilson; Michelle R Arkin; Arthur Weiss; John Kuriyan
Journal:  Biochem J       Date:  2015-01-01       Impact factor: 3.857

4.  Identification of Inhibitors of the Association of ZAP-70 with the T Cell Receptor by High-Throughput Screen.

Authors:  Patrick R Visperas; Christopher G Wilson; Jonathan A Winger; Qingrong Yan; Kevin Lin; Michelle R Arkin; Arthur Weiss; John Kuriyan
Journal:  SLAS Discov       Date:  2016-12-13       Impact factor: 3.341

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.